Vaishampayan UN - Search Results

1

Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma.

Vaishampayan UN, Heilbrun LK, Shields AF, Lawhorn-Crews J, Baranowski K, Smith D, Flaherty LE. Vaishampayan UN, et al. Invest New Drugs. 2007 Feb;25(1):69-75. doi: 10.1007/s10637-006-9005-8. Epub 2006 Aug 26. Invest New Drugs. 2007. PMID: 16937078 Clinical Trial.

2

Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma.

Vaishampayan U, Glode M, Du W, Kraft A, Hudes G, Wright J, Hussain M. Vaishampayan U, et al. Clin Cancer Res. 2000 Nov;6(11):4205-8. Clin Cancer Res. 2000. PMID: 11106233 Clinical Trial.

3

Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer.

Hussain M, Vaishampayan U, Du W, Redman B, Smith DC. Hussain M, et al. J Clin Oncol. 2001 May 1;19(9):2527-33. doi: 10.1200/JCO.2001.19.9.2527. J Clin Oncol. 2001. PMID: 11331332

4

Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.

Jimenez RE, Hussain M, Bianco FJ Jr, Vaishampayan U, Tabazcka P, Sakr WA, Pontes JE, Wood DP Jr, Grignon DJ. Jimenez RE, et al. Clin Cancer Res. 2001 Aug;7(8):2440-7. Clin Cancer Res. 2001. PMID: 11489824

5

Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma.

Vaishampayan U, Flaherty L, Du W, Hussain M. Vaishampayan U, et al. Cancer. 2001 Aug 1;92(3):519-23. doi: 10.1002/1097-0142(20010801)92:3<519::aid-cncr1350>3.0.co;2-#. Cancer. 2001. PMID: 11505395 Clinical Trial.

6

A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies.

Vaishampayan UN, Ben-Josef E, Philip PA, Vaitkevicius VK, Du W, Levin KJ, Shields AF. Vaishampayan UN, et al. Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):675-9. doi: 10.1016/s0360-3016(02)02772-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12062611

7

Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha.

Vaishampayan U, Abrams J, Darrah D, Jones V, Mitchell MS. Vaishampayan U, et al. Clin Cancer Res. 2002 Dec;8(12):3696-701. Clin Cancer Res. 2002. PMID: 12473578 Review.

8

An active regimen of weekly paclitaxel and estramustine in metastatic androgen-independent prostate cancer.

Vaishampayan U, Fontana J, Du W, Hussain M. Vaishampayan U, et al. Urology. 2002 Dec;60(6):1050-4. doi: 10.1016/s0090-4295(02)01990-8. Urology. 2002. PMID: 12475668 Clinical Trial.

9

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer.

Hussain M, Smith DC, El-Rayes BF, Du W, Vaishampayan U, Fontana J, Sakr W, Wood D. Hussain M, et al. Urology. 2003 Apr;61(4):774-80. doi: 10.1016/s0090-4295(02)02519-0. Urology. 2003. PMID: 12670564 Clinical Trial.

10

Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer.

El-Rayes BF, Zalupski MM, Shields AF, Vaishampayan U, Heilbrun LK, Jain V, Adsay V, Day J, Philip PA. El-Rayes BF, et al. J Clin Oncol. 2003 Aug 1;21(15):2920-5. doi: 10.1200/JCO.2003.03.022. J Clin Oncol. 2003. PMID: 12885810 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters